Evaluation of Port Delivery System with ranibizumab for the treatment of neovascular age-related macular degeneration | Therapeutic Delivery
Ophthalmology Management - SUSTAINED ANTI-VEGF DELIVERY
Port Delivery System Delivers Medication Via an Implant
Optometric Management - July 2020
Port Delivery System implant is noninferior to intravitreal ranibizumab for neovascular AMD - American Academy of Ophthalmology
Ranibizumab port delivery system: a clinical perspective | BMJ Open Ophthalmology
Roche's Port Delivery System Approved, Paving The Way For Ophthalmology Expansion :: Scrip
The promise of PDS in real-world practice
The Port Delivery System with Ranibizumab for Neovascular Age-Related Macular Degeneration: Results from the Randomized Phase 2 Ladder Clinical Trial - ScienceDirect
New implant technology safely minimizes injections for people with macular degeneration
Breaking the Burden: A New Way to Deliver Anti-VEGF
Implant Reduces Treatment Burden in Wet Macular Degeneration
Retina Global - Vision outcomes using a port delivery system proved equivalent to ranibizumab injections and showed a positive benefit profile. #PDS #nAMD #antiVEGF http://bit.ly/3nqW8aS | Facebook
The promise of PDS in real-world practice
The Port Delivery System with Ranibizumab for Neovascular Age-Related Macular Degeneration: Results from the Randomized Phase 2 Ladder Clinical Trial - ScienceDirect
La FDA acepta la solicitud de administración de ranibizumab a través del sistema Port Delivery System (PDS) para para el tratamiento de la DMAE neovascular - Asociación Mácula Retina
In-vitro characterization of ranibizumab release from the Port Delivery System - ScienceDirect
Retinal Physician - The Port Delivery System With Ranibizumab
Company Name
Ophthalmology Exams - Port Delivery System - Susvimo | Facebook
Retinal Physician - Tips and Tricks for the Port Delivery System
A custom virtual reality training solution for ophthalmologic surgical clinical trials | Advances in Simulation | Full Text
FDA Approves Genentech's Port Delivery System, Susvimo, a First-of-Its-Kind Therapeutic Approach for Wet AMD
Long-Acting Anti-VEGF Delivery
